日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Precision medicine in cutaneous melanoma-A comprehensive review

皮肤黑色素瘤精准医疗——一项综合综述

Reitmajer, Markus; Flatz, Lukas

Characterization of long-term survivors with liver metastases from uveal melanoma diagnosed between 2005 and 2021

对2005年至2021年间诊断出的葡萄膜黑色素瘤肝转移长期生存者的特征分析

Laukhuf, Jona; Wiens, Lisa; Grözinger, Gerd; Dittmann, Helmut; Thiel, Karolin; Leiter, Ulrike; Amaral, Teresa; Nanz, Lena; Flatz, Lukas; Reitmajer, Markus; Forschner, Andrea

Treatment at the end of life in patients with advanced melanoma. A multicenter DeCOG study of 1067 patients from the prospective skin cancer registry ADOReg

晚期黑色素瘤患者临终关怀:一项来自前瞻性皮肤癌登记处 ADOReg 的多中心 DeCOG 研究,纳入 1067 例患者。

Forschner, Andrea; Kähler, Katharina C; Gschnell, Martin; Langan, Ewan A; Weishaupt, Carsten; Meiss, Frank; Thoms, Kai-Martin; Wahl, Renate U; Göppner, Daniela; Garzarolli, Marlene; Sachse, Michael; Schlaak, Max; Reitmajer, Markus; Kellner, Ivonne; Gesierich, Anja; Mohr, Peter; Meier, Friedegund; von Wasielewski, Imke; Herbst, Rudolf; Utikal, Jochen; Pföhler, Claudia; Ulrich, Jens; Terheyden, Patrick; Kaatz, Martin; Haferkamp, Sebastian; Leiter, Ulrike; Ugurel, Selma; Weichenthal, Michael; Berking, Carola; Gutzmer, Ralf; Schadendorf, Dirk; Nanz, Lena; Loquai, Carmen

Comparative real-world outcomes of stage III melanoma patients treated with talimogene laherparepvec or interleukin 2

比较接受 talimogene laherparepvec 或白细胞介素 2 治疗的 III 期黑色素瘤患者的真实世界疗效

Reitmajer, Markus; Nanz, Lena; Müller, Nina; Leiter, Ulrike; Amaral, Teresa; Aebischer, Valentin; Flatz, Lukas; Forschner, Andrea

Real-world management of patients with complete response under immune-checkpoint inhibition for advanced melanoma

晚期黑色素瘤患者接受免疫检查点抑制剂治疗后完全缓解的真实世界管理

Reitmajer, Markus; Livingstone, Elisabeth; Thoms, Kai-Martin; Heppt, Markus V; Meiss, Frank; Gesierich, Anja; Drexler, Konstantin; Heinzerling, Lucie; Meier, Friedegund; Menzer, Christian; Schlaak, Max; Zimmer, Lisa; Forschner, Andrea

Multi-Omics Tumor Immunogenicity Score Predicts Immunotherapy Outcome and Survival

多组学肿瘤免疫原性评分预测免疫治疗效果和生存率

Gschwind, Axel; Ballin, Nadja; Ott, Alexander; Forschner, Andrea; Knapp, Amelie; Öner, Öznur; Bitzer, Michael; Tabatabai, Ghazaleh; Hartkopf, Andreas; Groß, Thorben; Reitmajer, Markus; Schroeder, Christopher; Ossowski, Stephan; Armeanu-Ebinger, Sorin

Adjuvant anti-PD-1 therapy improves melanoma-specific survival in stage IIIC-IV melanoma patients with high tumor mutation burden and BRAF V600 mutation

辅助抗PD-1疗法可改善具有高肿瘤突变负荷和BRAF V600突变的IIIC-IV期黑色素瘤患者的黑色素瘤特异性生存期。

Forschner, Julia; Huynh, Julia; Schroeder, Christopher; Armeanu-Ebinger, Sorin; Seibel-Kelemen, Olga; Gschwind, Axel; Bonzheim, Irina; Eigentler, Thomas K; Amaral, Teresa; Ossowski, Stephan; Flatz, Lukas; Garbe, Claus; Forschner, Andrea; Reitmajer, Markus

Distress and Its Determinants in 820 Consecutive Melanoma Patients

820例连续黑色素瘤患者的痛苦及其决定因素

Reitmajer, Markus; Riedel, Petra; Garbe, Claus; Schäffeler, Norbert; Eigentler, Thomas K; Forschner, Andrea

Determining the role of basophil activation testing in reported type 1 allergy to beta-lactam antibiotics

确定嗜碱性粒细胞活化试验在已报道的1型β-内酰胺类抗生素过敏反应中的作用

Reitmajer, Markus; Strauss, Antonia; Klinger, Christian; Maaß, Maximiliane; Kempf, Wolfgang E; Fischer, Joerg; Kneilling, Manfred; Volc, Sebastian

Long-term survival of stage IV melanoma patients: evaluation on 640 melanoma patients entering stage IV between 2014 and 2017

IV期黑色素瘤患者的长期生存率:对2014年至2017年间进入IV期的640例黑色素瘤患者的评估

Reitmajer, Markus; Leiter, Ulrike; Nanz, Lena; Amaral, Teresa; Flatz, Lukas; Garbe, Claus; Forschner, Andrea